Showing results (281-290 of 299) with videos related to

Sort By:
Pageof 30
Molecular Oncology|May 30, 2018
Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migrationBianca Cioni, Ekaterina Nevedomskaya, Monique H M Melis, et al.
Urology|March 4, 2017
Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled TrialFlorian M E Wagenlehner, J W Olivier van Till, Jos G A Houbiers, et al.
Archives of Toxicology|May 22, 2015
The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) miceAnnette M Krais, Ewoud N Speksnijder, Joost P M Melis, et al.
Radiation Research|July 19, 2013
Comparison of established and emerging biodosimetry assaysK Rothkamm, C Beinke, H Romm, et al.
Visual Impairment Research|January 6, 2009
The Introduction of Bioptic Driving in The NetherlandsAart C Kooijman, Bart J M Melis-Dankers, Eli Peli, et al.
Nature Communications|September 10, 2020
Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasionBianca Cioni, Anniek Zaalberg, Judy R van Beijnum, et al.
Frontiers in Oncology|October 3, 2022
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020Jeffrey J Kooijman, Wilhelmina E van Riel, Jelle Dylus, et al.
Radiation Research|February 21, 2017
Using Clinical Signs and Symptoms for Medical Management of Radiation Casualties - 2015 NATO ExerciseH Dörr, M Abend, W F Blakely, et al.
Plos One|March 9, 2016
Tissue-Specific Suppression of Thyroid Hormone Signaling in Various Mouse Models of AgingW Edward Visser, Cíntia R Bombardieri, Chantal Zevenbergen, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Pageof 30